首页> 外文OA文献 >Fitness of Mycobacterium tuberculosis strains of the W-Beijing and Non-W-Beijing genotype
【2h】

Fitness of Mycobacterium tuberculosis strains of the W-Beijing and Non-W-Beijing genotype

机译:W-Beijing和非W-Beijing基因型的结核分枝杆菌菌株的适应性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Multidrug resistant tuberculosis (MDR-TB) is a major threat for global tuberculosis control. The W-Beijing Mycobacterium tuberculosis genotype has been associated with drug resistance. Elucidation of the mechanisms underlying this epidemiological finding may have an important role in the control of MDR-TB. The aim of this study was to evaluate the fitness of drug-susceptible and MDR M. tuberculosis strains of the W-Beijing genotype compared with that of Non-W-Beijing strains. Methodology/Principal Findings: Fitness of M. tuberculosis strains was determined by evaluating the difference in the growth curves obtained in the MGIT960 automated system and assessing the competitive growth capacity between W-Beijing and non-W-Beijing strains. The W-Beijing MDR strains had a significant longer lag phase duration compared to the other strains but did not present a significant fitness cost. When grown in competition they had an advantage only in medium containing 0.1% Tween 80. Conclusions/Significance: It was not possible to confirm a selective advantage of W-Beijing strains to grow, except for differences in their resistance to Tween 80. Further studies are needed to elucidate the putative advantage of W-Beijing strains compared to other genotypes.
机译:背景:耐多药结核病(MDR-TB)是全球结核病控制的主要威胁。北京结核分枝杆菌的基因型与耐药性有关。阐明这一流行病学发现的潜在机制可能在控制耐多药结核病中具有重要作用。这项研究的目的是评估W型北京基因型与非W型北京菌株的药敏性和耐多药结核分枝杆菌菌株的适应性。方法/主要发现:通过评估MGIT960自动化系统中获得的生长曲线的差异并评估W-Beijing与非W-Beijing菌株之间的竞争性生长能力,确定结核分枝杆菌菌株的适应性。与其他菌株相比,W-北京MDR菌株具有明显更长的滞后期持续时间,但没有明显的适应性成本。当在竞争中生长时,它们仅在含有0.1%Tween 80的培养基中具有优势。结论/意义:除它们对Tween 80的抗性差异外,无法确认W北京菌株的选择性生长优势。需要阐明W-Beijing菌株与其他基因型相比的假定优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号